Gamida Cell: Updated Data from Phase 1 Trial of NK Cell Therapy GDA-201 in Non-Hodgkin Lymphoma Presented at the ASH 2020 Meeting – CBI
Homepage /  Press Release /  Gamida Cell: Updated Data from Phase 1 Trial of NK Cell Therapy GDA-201 in Non-Hodgkin Lymphoma Presented at the ASH 2020 Meeting

Press Release

Gamida Cell: Updated Data from Phase 1 Trial of NK Cell Therapy GDA-201 in Non-Hodgkin Lymphoma Presented at the ASH 2020 Meeting